Release Date: 23/04/20 08:23 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 456.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%